Published in Int J Radiat Oncol Biol Phys on August 04, 2012
In regard to Yu et al. Int J Radiat Oncol Biol Phys (2013) 1.06
Side effects of yttrium-90 radioembolization. Front Oncol (2014) 0.93
(⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres. Eur J Nucl Med Mol Imaging (2014) 0.85
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres. Eur J Nucl Med Mol Imaging (2015) 0.83
Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy. EJNMMI Phys (2015) 0.80
Review of diagnostic uses of shunt fraction quantification with technetium-99m macroaggregated albumin perfusion scan as illustrated by a case of Osler-Weber-Rendu syndrome. Ann Thorac Med (2016) 0.80
Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization. EJNMMI Res (2014) 0.77
In reply to Gates and Salem. Int J Radiat Oncol Biol Phys (2013) 0.75
Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts? PLoS One (2015) 0.75
Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med (2010) 6.05
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys (2002) 5.16
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys (2009) 4.47
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol (2009) 3.99
Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys (2003) 3.14
Retrospective review of 120 celect inferior vena cava filter retrievals: experience at a single institution. J Vasc Interv Radiol (2012) 2.72
Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans. J Nucl Med (2005) 2.36
Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2005) 2.35
Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys (2005) 2.33
Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys (2003) 2.29
Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.81
Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.76
Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood (2004) 1.74
Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys (2004) 1.70
PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis. Int J Stroke (2012) 1.49
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol Ther (2009) 1.46
Nonvascular and portal vein applications of cone-beam computed tomography: current status. Tech Vasc Interv Radiol (2013) 1.42
Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol Ther (2007) 1.40
Macroaggregated albumin injected in hepatic artery visualized in a recanalized paraumbilical vein. Clin Nucl Med (2012) 1.40
Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer (2008) 1.31
The COMBREX project: design, methodology, and initial results. PLoS Biol (2013) 1.24
Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther (2009) 1.22
The amplatzer vascular plug: a review of the device and its clinical applications. Cardiovasc Intervent Radiol (2012) 1.21
Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.19
Fracture and distant migration of the Bard Recovery filter: a retrospective review of 363 implantations for potentially life-threatening complications. J Vasc Interv Radiol (2011) 1.19
Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys (2008) 1.16
The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets. Int J Radiat Oncol Biol Phys (2002) 1.15
Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys (2007) 1.15
Confocal mosaicing microscopy of human skin ex vivo: spectral analysis for digital staining to simulate histology-like appearance. J Biomed Opt (2011) 1.12
Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys (2008) 1.11
Investigation of the use of MOSFET for clinical IMRT dosimetric verification. Med Phys (2002) 1.09
Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys (2007) 1.05
Penetration of Celect inferior vena cava filters: retrospective review of CT scans in 265 patients. AJR Am J Roentgenol (2014) 1.05
Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol (2011) 1.04
Unfaithful maintenance of methylation imprints due to loss of maternal nuclear Dnmt1 during somatic cell nuclear transfer. PLoS One (2011) 1.04
Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers. J Vasc Interv Radiol (2009) 1.04
Nephron-sparing nephrectomy for giant renal angiomyolipoma associated with lymphangioleiomyomatosis. Urology (2002) 1.04
Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int (2014) 1.03
Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine (2012) 1.03
Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.00
Utility of the Amplatzer Vascular Plug in splenic artery embolization: a comparison study with conventional coil technique. Cardiovasc Intervent Radiol (2010) 0.99
Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer. Int J Radiat Oncol Biol Phys (2008) 0.99
Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys (2008) 0.98
Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys (2007) 0.98
Fracture and migration of Celect inferior vena cava filters: a retrospective review of 741 consecutive implantations. J Vasc Interv Radiol (2013) 0.96
Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose. Int J Radiat Oncol Biol Phys (2005) 0.95
Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data. Int J Radiat Oncol Biol Phys (2012) 0.95
Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells. Mol Ther (2004) 0.94
A population-based atlas and clinical target volume for the head-and-neck lymph nodes. Int J Radiat Oncol Biol Phys (2004) 0.93
Dose calculation using megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys (2007) 0.93
A new smoothing procedure to reduce delivery segments for static MLC-based IMRT planning. Med Phys (2004) 0.93
Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. Int J Radiat Oncol Biol Phys (2011) 0.93
Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2003) 0.93
Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Eur J Nucl Med Mol Imaging (2005) 0.91
Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med (2008) 0.91
Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys (2010) 0.90
Molecular characterization of the human NANOG protein. Stem Cells (2009) 0.90
A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 0.90
Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy. J Appl Clin Med Phys (2013) 0.87
Aberrant expression and methylation status of putatively imprinted genes in placenta of cloned piglets. Cell Reprogram (2010) 0.87
Assessing feasibility of real-time ultrasound monitoring in stereotactic body radiotherapy of liver tumors. Technol Cancer Res Treat (2013) 0.86
Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 0.86
Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis. J Clin Microbiol (2011) 0.86
Comprehensive analysis of the anterolateral thigh flap vascular anatomy. Arch Facial Plast Surg (2011) 0.85
Tbx3 and Nr5α2 play important roles in pig pluripotent stem cells. Stem Cell Rev (2013) 0.85
Detection of treatment setup errors between two CT scans for patients with head and neck cancer. Med Phys (2007) 0.84
Biomedical imaging research opportunities workshop IV: a white paper. Med Phys (2007) 0.83
Acute abdominal pain after retrievable inferior vena cava filter insertion: case report of caval perforation by an option filter. Cardiovasc Intervent Radiol (2011) 0.83
Germinal vesicle chromatin configurations of bovine oocytes. Microsc Res Tech (2006) 0.83
Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. J Appl Clin Med Phys (2015) 0.83
An algorithm for shifting MLC shapes to adjust for daily prostate movement during concurrent treatment with pelvic lymph nodes. Med Phys (2007) 0.82
Image-guided radiotherapy using megavoltage cone-beam computed tomography for treatment of paraspinous tumors in the presence of orthopedic hardware. Int J Radiat Oncol Biol Phys (2006) 0.82
Basics of magnetic resonance imaging. Semin Vasc Surg (2004) 0.82
Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors. Bioorg Med Chem Lett (2005) 0.81
Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma. Clin Lymphoma Myeloma Leuk (2011) 0.81
Effects of the intensity levels and beam map resolutions on static IMRT plans. Med Phys (2004) 0.81
A feasibility study of using conventional jaws to deliver IMRT plans in the treatment of prostate cancer. Phys Med Biol (2007) 0.81
Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodes. Int J Radiat Oncol Biol Phys (2013) 0.81
Can posterior dynamic stabilization reduce the risk of adjacent segment deterioration? Turk Neurosurg (2013) 0.80
Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat (2012) 0.80
Multimodality treatment of neuroendocrine liver metastases. Surgery (2011) 0.80
Dosimetric impact of orthopedic metal artifact reduction (O-MAR) on Spine SBRT patients. J Appl Clin Med Phys (2015) 0.79
Comparison of intensity-modulated radiosurgery with gamma knife radiosurgery for challenging skull base lesions. Int J Radiat Oncol Biol Phys (2003) 0.79
Percutaneous transrenal hemodialysis catheter insertion. J Vasc Interv Radiol (2002) 0.79
Combined use of preoperative provocative angiography and highly selective methylene blue injection to localize an occult small-bowel bleeding site in a patient with Crohn's disease: report of a case. Dis Colon Rectum (2003) 0.79
Effect of MLC leaf width on treatment adaptation and accuracy for concurrent irradiation of prostate and pelvic lymph nodes. Med Phys (2013) 0.79
Value of FDG PET in the evaluation of therapy response in nerve root neurolymphomatosis. Clin Nucl Med (2011) 0.78
Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy. Radiother Oncol (2008) 0.78
Effect of implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of water and sodium MRI. NMR Biomed (2011) 0.78
Time to hemostasis after traction removal of tunneled cuffed central venous catheters. J Vasc Interv Radiol (2007) 0.78
The current status of image-guided external beam radiotherapy for prostate cancer. Curr Opin Urol (2010) 0.78
A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2007) 0.78
Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2011) 0.78
Randomized comparison of split tip versus step tip high-flow hemodialysis catheters. Kidney Int (2002) 0.78
Simplifying intensity-modulated radiotherapy plans with fewer beam angles for the treatment of oropharyngeal carcinoma. J Appl Clin Med Phys (2007) 0.78